Literature DB >> 26453502

Inflammation induced loss of skeletal muscle.

Priya Londhe1, Denis C Guttridge2.   

Abstract

Inflammation is an important contributor to the pathology of diseases implicated in skeletal muscle dysfunction. A number of diseases and disorders including inflammatory myopathies and Chronic Obstructive Pulmonary Disorder (COPD) are characterized by chronic inflammation or elevation of the inflammatory mediators. While these disease states exhibit different pathologies, all have in common the loss of skeletal muscle mass and a deregulated skeletal muscle physiology. Pro-inflammatory cytokines are key contributors to chronic inflammation found in many of these diseases. This section of the review focuses on some of the known inflammatory disorders like COPD, Rheumatoid Arthritis (RA) and inflammatory myopathies that display skeletal muscle atrophy and also provides the reader an overview of the mediators of inflammation, their signaling pathways, and mechanisms of action. This article is part of a Special Issue entitled "Muscle Bone Interactions".
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrophy; Cytokines; Differentiation; Inflammation; Muscle; Skeletal

Mesh:

Substances:

Year:  2015        PMID: 26453502      PMCID: PMC4600538          DOI: 10.1016/j.bone.2015.03.015

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  248 in total

Review 1.  Polymyositis and dermatomyositis.

Authors:  Marinos C Dalakas; Reinhard Hohlfeld
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

2.  Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis.

Authors:  A Rebbapragada; H Benchabane; J L Wrana; A J Celeste; L Attisano
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

3.  Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy.

Authors:  Marco Sandri; Claudia Sandri; Alex Gilbert; Carsten Skurk; Elisa Calabria; Anne Picard; Kenneth Walsh; Stefano Schiaffino; Stewart H Lecker; Alfred L Goldberg
Journal:  Cell       Date:  2004-04-30       Impact factor: 41.582

4.  Gamma interferon as an antifibrosis agent in skeletal muscle.

Authors:  William Foster; Yong Li; Arvydas Usas; George Somogyi; Johnny Huard
Journal:  J Orthop Res       Date:  2003-09       Impact factor: 3.494

5.  Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells.

Authors:  Guillaume Page; Guillaume Chevrel; Pierre Miossec
Journal:  Arthritis Rheum       Date:  2004-01

6.  p38 MAPK-induced nuclear factor-kappaB activity is required for skeletal muscle differentiation: role of interleukin-6.

Authors:  Bernat Baeza-Raja; Pura Muñoz-Cánoves
Journal:  Mol Biol Cell       Date:  2004-02-06       Impact factor: 4.138

7.  Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression.

Authors:  Stewart H Lecker; R Thomas Jagoe; Alexander Gilbert; Marcelo Gomes; Vickie Baracos; James Bailey; S Russ Price; William E Mitch; Alfred L Goldberg
Journal:  FASEB J       Date:  2004-01       Impact factor: 5.191

8.  Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase.

Authors:  Seoung Woo Lee; Guoli Dai; Zhaoyong Hu; Xiaonan Wang; Jie Du; William E Mitch
Journal:  J Am Soc Nephrol       Date:  2004-06       Impact factor: 10.121

9.  Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study.

Authors:  L B A van de Putte; R Rau; F C Breedveld; J R Kalden; M G Malaise; P L C M van Riel; M Schattenkirchner; P Emery; G R Burmester; H Zeidler; H M Moutsopoulos; K Beck; H Kupper
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

Review 10.  Interferon-gamma: an overview of signals, mechanisms and functions.

Authors:  Kate Schroder; Paul J Hertzog; Timothy Ravasi; David A Hume
Journal:  J Leukoc Biol       Date:  2003-10-02       Impact factor: 4.962

View more
  82 in total

1.  Liver kinase B1 inhibits the expression of inflammation-related genes postcontraction in skeletal muscle.

Authors:  Ting Chen; Timothy M Moore; Mark T W Ebbert; Natalie L McVey; Steven R Madsen; David M Hallowell; Alexander M Harris; Robin E Char; Ryan P Mackay; Chad R Hancock; Jason M Hansen; John S Kauwe; David M Thomson
Journal:  J Appl Physiol (1985)       Date:  2016-01-21

2.  Creatine supplementation in Walker-256 tumor-bearing rats prevents skeletal muscle atrophy by attenuating systemic inflammation and protein degradation signaling.

Authors:  Paola S Cella; Poliana C Marinello; Fernando H Borges; Diogo F Ribeiro; Patrícia Chimin; Mayra T J Testa; Philippe B Guirro; José A Duarte; Rubens Cecchini; Flávia A Guarnier; Rafael Deminice
Journal:  Eur J Nutr       Date:  2019-02-26       Impact factor: 5.614

3.  Hydrogen sulfide alleviates hyperhomocysteinemia-mediated skeletal muscle atrophy via mitigation of oxidative and endoplasmic reticulum stress injury.

Authors:  Avisek Majumder; Mahavir Singh; Jyotirmaya Behera; Nicholas T Theilen; Akash K George; Neetu Tyagi; Naira Metreveli; Suresh C Tyagi
Journal:  Am J Physiol Cell Physiol       Date:  2018-08-15       Impact factor: 4.249

4.  Effect of IL-1β, TNF-α and IGF-1 on trans-endothelial passage of synthetic vectors through an in vitro vascular endothelial barrier of striated muscle.

Authors:  J P Gomez; C Gonçalves; C Pichon; P Midoux
Journal:  Gene Ther       Date:  2017-05-15       Impact factor: 5.250

5.  Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy.

Authors:  Mehmet Asim Bilen; Dylan J Martini; Yuan Liu; Julie M Shabto; Jacqueline T Brown; Milton Williams; Amir I Khan; Alexandra Speak; Colleen Lewis; Hannah Collins; Haydn T Kissick; Bradley C Carthon; Mehmet Akce; Walid L Shaib; Olatunji B Alese; Rathi N Pillai; Conor E Steuer; Christina S Wu; David H Lawson; Ragini R Kudchadkar; Bassel F El-Rayes; Suresh S Ramalingam; Taofeek K Owonikoko; R Donald Harvey; Viraj A Master
Journal:  Oncologist       Date:  2019-12-05

Review 6.  STAT3 in the systemic inflammation of cancer cachexia.

Authors:  Teresa A Zimmers; Melissa L Fishel; Andrea Bonetto
Journal:  Semin Cell Dev Biol       Date:  2016-02-06       Impact factor: 7.727

7.  Lysophosphatidic acid-induced RhoA signaling and prolonged macrophage infiltration worsens fibrosis and fatty infiltration following rotator cuff tears.

Authors:  Michael R Davies; Lawrence Lee; Brian T Feeley; Hubert T Kim; Xuhui Liu
Journal:  J Orthop Res       Date:  2016-08-19       Impact factor: 3.494

Review 8.  Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function.

Authors:  James Frampton; Kevin G Murphy; Gary Frost; Edward S Chambers
Journal:  Nat Metab       Date:  2020-03-30

9.  Comprehensive Multi-omics Analysis Reveals Mitochondrial Stress as a Central Biological Hub for Spaceflight Impact.

Authors:  Willian A da Silveira; Hossein Fazelinia; Sara Brin Rosenthal; Evagelia C Laiakis; Man S Kim; Cem Meydan; Yared Kidane; Komal S Rathi; Scott M Smith; Benjamin Stear; Yue Ying; Yuanchao Zhang; Jonathan Foox; Susana Zanello; Brian Crucian; Dong Wang; Adrienne Nugent; Helio A Costa; Sara R Zwart; Sonja Schrepfer; R A Leo Elworth; Nicolae Sapoval; Todd Treangen; Matthew MacKay; Nandan S Gokhale; Stacy M Horner; Larry N Singh; Douglas C Wallace; Jeffrey S Willey; Jonathan C Schisler; Robert Meller; J Tyson McDonald; Kathleen M Fisch; Gary Hardiman; Deanne Taylor; Christopher E Mason; Sylvain V Costes; Afshin Beheshti
Journal:  Cell       Date:  2020-11-25       Impact factor: 41.582

10.  Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia.

Authors:  Kah Poh Loh; Janet A Tooze; Barbara J Nicklas; Stephen B Kritchevsky; Jeff D Williamson; Leslie R Ellis; Bayard L Powell; Timothy S Pardee; Neha G Goyal; Heidi D Klepin
Journal:  J Geriatr Oncol       Date:  2019-04-05       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.